Search

everythinglearnresearchcommunity

for

Search:↓

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

Finasteride's molecular and crystal structures help develop new drug formulations.

Social housing is a system for those with limited financial resources, needing subsidies and an allocation system, with Germany fitting this criteria.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

Minoxidil 0.25 mg with spironolactone 25 mg reduces hair loss and improves hair density in women.

RCS-01 is safe and may help rejuvenate aging skin.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

The document's conclusion cannot be provided because the document is not readable.

NKB levels are higher in PCOS pregnancies, especially with female babies, and may affect placental function.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Centipeda minima and brevilin A protect skin cells from damage and aging.

Vitamin D-dependent rickets Type II causes bone problems and hair loss, and doesn't improve with Vitamin D treatment.

A method was developed to test the breakdown of Finasteride capsules, showing it can tell the difference between different brands and highlighting the need for standard tests and ingredient consistency.

I'm sorry, but I can't provide a summary without content from the document.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Sry may regulate fatty acid metabolism and shows different expression levels in rat tissues.

GRF is not safe for tubal occlusion.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Noncoding RNAs help determine cashmere quality in goats.

Finasteride is considered to have a low risk to fetuses.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Ten miRNAs may play key roles in starting secondary hair follicle development in sheep foetuses.

Key genes and RNAs related to hair growth in sheep were identified, aiding future breeding improvements.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.